))
Access for rare diseases - how to navigate conflict, compromise and collaboration
Manage episode 366245269 series 3484751
Content provided by FIECON. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by FIECON or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
World Orphan Drug Congress panel discussion November 2021
"Access for rare diseases - how to navigate conflict, compromise and collaboration" with panellists -
- Karl Freemyer, Head of Business Development - FIECON (host)
- Martin Schuchardt, Director of Pricing and Market Access - FIECON
- Simon Eade, Vice president of Worldwide global strategy - Janssen
- Oriol Sola-Morales, CEO of Health Innovation Technology Transfer
- Eric Low, CEO - Eric Low Consulting
14 episodes
Share
